スポンサーリンク
Department Of Otorhinolaryngology Yokohama City University School Of Medicine | 論文
- Antedrug Budesonide by Intrapulmonary Treatment Attenuates Bleomycin-Induced Lung Injury in Rats with Minimal Systemic Adverse Effects
- COMEDOGENICITY OF SQUALENE MONOHYDROPEROXIDE IN THE SKIN AFTER TOPICAL APPLICATION
- Good Laboratory Practice (GLP) status of Asian countries and its implementation in non-clinical safety studies in pharmaceutical drug development
- WS1-5-4 Ejaculatory Dysfunction Caused by New α1-blocker : Analysis of Human Ejaculatory Phenomenon Using Color Doppler Ultrasonography(Andrology)
- Posttreatment M-Protein Nadir Level Is a Significant Prognostic Factor Associated with Survival in Multiple Myeloma
- An Antioxidant, Probucol, Induces Anti-angiogenesis and Apoptosis in Athymic Nude Mouse Xenografted Human Head and Neck Squamous Carcinoma Cells
- A Selective Cyclooxygenase-2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma Cells
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Decrease of creatinine clearance rate with aging in patients with head and neck cancer in Japan
- Superior Efficacy of MMCP Regimen Compared with VMCP and MMPP Regimens in the Treatment of Multiple Myeloma
- Characterization of a novel Neuropilin-1 targeted hybrid peptide disintegrating cancer cell membrane
- Antitumor effect of the EGFR-lytic hybrid peptide in animal model of human cancers with K-ras mutation
- Effective in vitro and in vivo Antitumor Activity of Hybrid IL4-lytic Peptide
- An Experimental Model of Tumor Dormancy Therapy for Advanced Head and Neck Carcinoma
- Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas
- Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities
- Cytotoxic activity to acute myeloid leukemia cells by Antp-TPR hybrid peptide targeting Hsp90(MEDICAL BIOTECHNOLOGY)
- A Survey of Physicians Understanding of the Regulatory Systems for Clinical Trials in Japan